Article
Recent advances in targeted therapies in acute myeloid leukemia.
Journal of hematology & oncology - 25 Mar 2023
Bhansali Rahul S, Pratz Keith W, Lai Catherine
Abstract excerpt
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell transplantation (alloHSCT), this effect has been largely mitigated in older and less fit patients as well as those with adverse-risk disease characteristics....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
